Table 5.
Summary of the visual analog scale (VAS).
| Assessment | Group A (PCSO-524™; stage I) | Group B (Fish oil; stage I) | Group C (PCSO-524™; stage II) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| week | week | week | |||||||||||
| 0 | 4 | 8 | 12 | 0 | 4 | 8 | 12 | 0 | 4 | 8 | 12 | ||
| Pain | mean/median * | 66.00 | 31.56 | 8.00 | 1.00 | 66.39 | 65.45 | 64.91 | 69.00 | 56.00 | 22.50 | 8.00 | 1.00 |
| SD/IQR ** | 11.48 | 12.46 | 9.00 | 3.00 | 16.01 | 15.89 | 16.26 | 30.00 | 25.00 | 28.00 | 9.00 | 3.00 | |
| min | / | / | 0.00 | 0.00 | / | / | / | 35.00 | 15.00 | 8.00 | 0.00 | 0.00 | |
| max | / | / | 55.00 | 61.00 | / | / | / | 80.00 | 92.00 | 77.00 | 55.00 | 61.00 | |
| distribution | nor | nor | nnor | nnor | nor | nor | nor | nnor | nnor | nnor | nnor | nnor | |
| Disease activity | mean/median * | 62.64 | 25.04 | 6.00 | 1.00 | 62.57 | 62.64 | 59.67 | 60.00 | 56.09 | 27.64 | 11.50 | 6.00 |
| SD/IQR ** | 13.15 | 10.17 | 8.00 | 3.00 | 15.54 | 16.34 | 15.70 | 33.00 | 18.30 | 18.31 | 7.00 | 6.00 | |
| min | / | / | 0.00 | 0.00 | / | / | / | 31.00 | / | / | 3.00 | 3.00 | |
| max | / | / | 56.00 | 54.00 | / | / | / | 79.00 | / | / | 74.00 | 55.00 | |
| distribution | nor | nor | nnor | nnor | nor | nor | nor | nnor | nor | nor | nnor | nnor | |
| General health | mean/median * | 62.96 | 25.52 | 13.00 | 2.00 | 61.00 | 62.68 | 61.10 | 65.00 | 54.00 | 33.00 | 17.00 | 9.50 |
| SD/IQR ** | 12.57 | 11.29 | 11.00 | 4.00 | 38.00 | 14.63 | 15.13 | 35.00 | 20.00 | 30.00 | 12.00 | 8.00 | |
| min | / | / | 9.00 | 0.00 | 35.00 | / | / | 34.00 | 8.00 | 8.00 | 4.00 | 5.00 | |
| max | / | / | 0.00 | 53.00 | 89.00 | / | / | 83.00 | 9.00 | 70.00 | 64.00 | 50.00 | |
| distribution | nor | nor | nnor | nnor | nnor | nor | nor | nnor | nnor | nnor | nnor | nnor | |
*—in nor, median in nnor distribution; **—SD in nor, IQR in nnor distribution; nor = normally (parametrically); nnor = non-parametrically; p-Values: Pain: A vs. B = significant; B vs. C = significant; A vs. C = not significant; Disease activity: A vs. B = significant; B vs. C = not significant; A vs. C = not significant; General health: A vs. B = significant; B vs. C = significant; A vs. C = not significant; VAS Pain scoring: 100–80: agonizing to horrible; 80–60: horrible to dreadful; 60–40: dreadful to uncomfortable; 40–20: uncomfortable to annoying; 20–0: annoying to none.